- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
Patient Advocates are Grateful States are Listening, Warn “There is More Action Still Needed”
WASHINGTON, DC — Last Monday, March 16, Americans for Safe Access (ASA), the nation's largest medical cannabis patient advocacy organization, with coordinated stakeholders and allies, called on U.S. state and territorial governors (DC mayor) and medical cannabis program directors to allow cannabis businesses and dispensaries to remain open as “essential” businesses during COVID-19-related closings as well as a list of other measures that they should immediately put into place to protect patient access and the medical cannabis supply chain.
“18 states have now declared cannabis businesses essential, said ASA Founder and President Steph Sherer. “And, many others are following other ASA recommendations, such as instructing medical cannabis businesses on how they can make legal temporary changes to their business plans. These include expanding delivery services, allowing curbside pickup, extending the expiration date of state-issued cannabis identification cards, and allowing telehealth visits for new and renewing medical cannabis certifications,” Sherer said. “We applaud these efforts at the state level and are honored to serve governments and medical cannabis stakeholders on behalf of patients.”
ASA will continue to monitor officials’ responses to the unfolding COVID-19 pandemic and will take further action as necessary to ensure that patients can continue to access the medicine on which they rely for their well-being.
To learn more about updates to how states and businesses are responding to the COVID-19 crisis, our recommendations to patients, and how patients can urge governments to take action, ASA has created a COVID-19 resource page: https://www.safeaccessnow.org/COVID-19